-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SETDB1 As a Therapeutic Target in Monocytic Acute Myeloid Leukemia

Scientific Workshop on Myeloid Development
Program: Scientific Workshops
Session: Signaling and Development
Friday, December 8, 2023, 2:45 PM-3:33 PM

Susumu Goyama, MD

The University of Tokyo, Tokyo, Japan

Disclosures: Goyama: Janssen: Research Funding; Toshiba: Research Funding.